Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY

Benzinga
11 Oct 2024

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growth

GUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US FDA 510(k) clearances, today announced its preliminary financial results for the six months ended June 30, 2024 (the "First Half of 2024").

First Half of 2024 Financial Highlights

  • Total revenues reached US$13.1 million, representing an increase of 13.8% from US$11.5 million in the same period of 2023.
  • Gross profit increased by 20.9% to US$11.5 million from US$9.5 million in the first half of 2023.
  • Operating income was US$5.1 million, representing an increase of 70.0% from US$3.0 million in the same period of 2023.
    • Net income increased by 85.8% to US$4.4 million from US$2.4 million in the first half of 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10